UK – A mutant wfs1 zebrafish model of Wolfram syndrome manifesting visual dysfunction and developmental delay – October 2021
The team at Cambridge, UK are now working on the next phase – developing this zebrafish model further to fluorescently label various retinal cell types.
USA – How a cheap antidepressant emerged as a promising Covid-19 treatment – September 2021
Some of you may have heard of research that was being done in USA, looking at the treatment of Covid with Luvox. Luvox is an antidepressant that Dr. Angela Reiersen at Wash U (works with Fumi et al) found was particularly effective for people with Wolfram Syndrome who have anxiety/depression. She made a remarkable connection between the anti-inflammatory action of Luvox and it’s possible mechanisms of action in Wolfram Syndrome, and then extrapolated that to people with Covid…
Realising that the anti-inflammatory mechanism could help people with Covid. It looks like she was right; the article below talks about this and there are several other published articles that took off after she made the connection.
Once again, this ultra rare disease is helping to solve some other really big problems.
UK – Therapeutic Advances in Rare Disease – August 2021
A recently published review from Dr Patrick Yu Wai Man’s team at Cambridge University Hospital.
USA – Trial and Research Updates from Dr Fumi Urano – August 2021
Spain Gene Therapy to get a treatment for Wolfram Syndrome – Spanish WS Association – August 2021
We are proud to announce that, together with researchers from the Autonomous University of Barcelona (UAB), we have started the first gene therapy project for Wolfram Syndrome
UK TREATWolfram Trial Update – Prof Barrett – June 2021
USA Trial and Research Updates from Dr Fumi Urano – May 2021
Acknowledgments also to the White Foundation for their help in referring patients to Dr Urano’s research. They were unfortunately omitted from the blog sent out in the newsletter.
Portugal – Wolfram syndrome: a Portuguese Research – May 2021
USA Psychiatric Diagnoses and Treatment in Wolfram Syndrome
UK TREATWolfram Trial – update from Prof Tim Barrett – February 2021
Estonian Research February 2021 – Liraglutide, 7,8-DHF and their co-treatment prevents loss of vision and cognitive decline in a Wolfram syndrome rat model.
UK TREATWolfram Trial – Adult’s update from Dr Ben Wright – February 2021
Due to continued Coronavirus pressure this year on delivery of adult Queen Elizabeth hospital medical services, we were requested to pause further recruitment to the TreatWolfram study. This was disappointing, but understandable. We remain committed to the safe delivery of this trial, and will seek to re-open recruitment again as soon as permitted to do so. People currently enrolled to the trial will continue to be supported by the trial team. Whilst some members of the trial team have been redeployed to other hospital roles during this time they will continue to respond to any trial questions raised but may take longer to do so. Their contact email is NeurologyResearchTeam@uhb.nhs.uk
USA Trial and Research Updates from Dr Fumi Urano – February 2021
Adult Trial Recruitment Webinar – 9th November 2020
Virtual Tour of I-Stem Research Labs, France – October 2020.
For those interested in research you might like to watch this short video from the I-Stem Research Centre in France.
I-Stem is the largest French laboratory for research and development dedicated to human pluripotent stem cells, of embryonic origin or obtained by reprogramming gene. https://www.istem.eu/en/
The video has subtitles for the researchers speaking in French, so apologies to those who are VI.
USA Trial Update from Dr Fumi Urano – September 2020
TREATWolframTrial Update from Prof Tim Barrett – September 2020
TREATWolfram Update from Prof Barrett – 15th June 2020
TREATWolfram Adult Recruitment Update from Dr Wright – 12th June 2020
USA update from Dr Fumi Urano – 25th April 2020
An easy read version of the medical research paper below.
USA Research Paper – Diabetes reversed in mice with genetically edited stem cells derived from patients – April 2020
TREATWolfram Trial Update – March 2020
USA Update from Dr Fumi Urano – February 2020
Zebrafish Model Update, UK Research (linked information on 2018 trials page) – February 2020
TREATWolfram Trial Update – November 2019
Liraglutide Research Paper, Estonia – November 2019
Zebrafish Model Update, UK Research – October 2019
TREATWolfram Trial Update – August 2019
TREATWolfram Trial Update – April 2019
TREATWolfram Trial update January 2019
TREATWolfram Clinical Trial Update – 26th November 2018
How do faults in the WFS1 gene lead to cell death in Wolfram syndrome? – posted Feb 2020
USA Dantrolene Trial Update from Fumi Urano – 26th September 2018
TREATWOLFRAM clinical trial update – September 2018
TREATWolfram Trial Update from Prof Tim Barrett – 15th July 2018
TREATWolfram Trial Important Update from Prof Tim Barrett – 30 April 2018
Bio Markers update – April 2018
Accelerating clinical trials in Wolfram syndrome: development of efficacy biomarkers and patient relevant outcome measures 1st teleconference meeting report Tuesday 24 April, 2018
USA Dantrolene Trial Update – Dr Fumi Urano, 26 April 2018
TREATWolfram Update from Prof Tim Barrett – 26th February 2018
Biomarkers Research – 31 January 2018
What are biomarkers and why are they important
TREATWolfram Update from Professor Barrett – 27 November 2017
TREATWolfram Update from Prof Tim Barrett – 6 August 2017
USA Dantrolene Safety Trial Update, Dr Fumi Urano – 1st August 2017
TREATWolfram Update from Prof Barrett – 15th June 2017
TREATWolfram Update from Prof Barrett – 9th May 2017
Lay Person Summary for clinical drug trial by Prof Barrett– 1st March 2017
Research Update Letter – 24th February 2017